Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
108 studies found for:    Open Studies | Central Nervous System Infections
Show Display Options
Rank Status Study
1 Unknown  Long Term Outcomes of EV71 CNS Infection
Condition: Central Nervous System Infection
Intervention:
2 Unknown  Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)
Condition: Central Nervous System Infection
Intervention:
3 Recruiting Singapore Neurologic Infections Program
Condition: Central Nervous System Infections
Intervention:
4 Not yet recruiting Vietnam Cryptococcal Retention in Care Study
Conditions: Meningitis, Cryptococcal;   Central Nervous System Fungal Infections;   Central Nervous System Infections;   Meningitis, Fungal
Intervention: Drug: Fluconazole
5 Recruiting National Study on Listeriosis and Listeria
Conditions: Listeriosis;   Pregnancy Complications;   Infectious;   Central Nervous System Infections;   Septicemia;   Sepsis; Listeria Monocytogenes
Intervention:
6 Recruiting Biological Markers for the Diagnosis of the Central Nervous System Infection Disease.
Condition: Infection
Intervention:
7 Not yet recruiting Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis
Condition: Encephalitis
Interventions: Drug: Immunoglobulins, Intravenous (Privigen);   Drug: Placebo
8 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
9 Recruiting Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal (Groups A, C, Y and W135) Oligosaccharide Diphtheria CRM197Conjugate Vaccine;   Biological: Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed;   Biological: GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
10 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
11 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
12 Recruiting Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis;   Invasive Hib Infections
Intervention: Biological: Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine
13 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
14 Recruiting Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
Conditions: Meningitis;   Neurological Infections
Intervention: Drug: Ceftriaxone treatment
15 Recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
16 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
17 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
18 Recruiting A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants
Condition: Encephalitis
Interventions: Biological: 0.5ml experimental vaccine on day 0,7 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml experimental vaccine on day 0,28 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml active comparator vaccine on day 0,7 inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell)
19 Recruiting Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28
Conditions: Meningoccocal Disease,;   Meningococcal Meningitis
Interventions: Biological: rMenB + OMV vaccine (1 dose at study month zero);   Biological: rMenB + OMV vaccine (2 doses 1 month apart)
20 Unknown  Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Conditions: Seizures;   Pneumococcal Meningitis
Interventions: Drug: Phenytoin;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years